Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

Quick Stats
Studies 2230
Trials 95
Score 1
2025 pubmed

Comparative analysis of short-term and long-term LL-37-induced rosacea-like mouse models: Histopathological features and inflammatory immune responses.

Wu. Yiling Y; Zhang. Chuanxi C; Jin. Hui H; Zheng. Ruiping R; Li. Tian T; Jin. Fuyu F; Li. Yaqian Y; Gao. Xuemin X; Xu. Hong H; Wei. Zhongqiu Z; Yang. Jie J

Key Findings

  • Long‑term LL-37 exposure in mice creates a rosacea‑like skin condition with thickened skin, increased blood vessel growth, and enlarged sebaceous glands.
  • Short‑term LL-37 exposure mainly triggers innate immune responses, whereas long‑term exposure also activates adaptive immune pathways.
  • RNA sequencing revealed distinct gene expression changes linked to immune system dysregulation in the long‑term model.

Practical Outcomes

  • For most biohackers, this study offers limited direct use because it focuses on a disease model rather than a health‑boosting protocol. It does suggest that chronic exposure to LL-37 can provoke deeper immune changes, which might be relevant if you’re experimenting with antimicrobial peptides for skin health, but no actionable dosage or safety guidance is provided.

Summary

Scientists made two mouse models of rosacea using the peptide LL-37—one with short exposure and one with long exposure—to see how the skin and immune system change over time. The long‑term model showed thicker skin, more blood vessels, bigger oil glands, and activation of both innate and adaptive immunity, while the short‑term model mainly affected innate immunity.

Abstract

It is well recognized that developing new animal models, refining the existing mouse models, and thoroughly characterizing their features are essential for gaining a deeper understanding of rosacea pathogenesis and for advancing therapeutic strategies in this direction. Accordingly, we aimed to characterize the pathological features of a long-term LL-37-induced mouse model of rosacea and to compare the disease manifestations and pathophysiological characteristics between short-term and long-term LL-37-induced models. A key focus was to investigate differential gene expression and the underlying mechanisms of immune system dysregulation in these models. We comparatively assessed skin lesion manifestations, the extent of inflammatory infiltration, sebaceous gland alterations, fibrosis, and angiogenesis in both models. Assessments were performed using photographic documentation, hematoxylin-eosin (HE) staining, Van Gieson's (VG) staining, immunohistochemistry, and Western blotting. Furthermore, we employed RNA sequencing to analyze differential gene expression in mouse skin. The RNA sequencing data were validated using immunofluorescence staining and Western blotting, with a specific focus on gene variations and mechanisms related to immune system dysregulation. Mice subjected to long-term LL-37 induction developed rosacea-like pathological features, including angiogenesis, thickened skin tissue, and sebaceous gland hypertrophy. In the short-term LL-37-induced model, immune dysregulation primarily involved the innate immune response. However, long-term LL-37 induction resulted in significant activation of both innate and adaptive immune responses. The long-term LL-37-induced mouse model offers a valuable animal model for the detailed investigation of the pathological mechanisms driving moderate-to-severe rosacea with prolonged disease duration. Importantly, this model provides a significant experimental foundation for exploring the potential role of immune system dysregulation in rosacea pathogenesis.

Study Information

Provider

pubmed

Year

2025

Date

2025-04-28T00:00:00.000Z

DOI

10.1002/ame2.70020

References

30